Using samples only a few microlitres in volume, experiments can be started sooner and finished faster, streamlining the entire research and development process
Available from Guava Technologies, the PCA is claimed to be the world's first personal cell analysis system, enabling scientists engaged in cell-based discovery to easily perform advanced assays with fewer cells than required by other methods. Using samples only a few microlitres in volume, experiments can be started sooner and finished faster, streamlining the entire R and D process.
As so little sample is required for each assay, the Guava PCA saves precious cells while still giving highly precise and accurate results.The Guava PCA system improves cell counting and viability measurements, as well as screening assays used by researchers everywhere for characterising cells.
Its ultra-compact size and ease of use makes the Guava PCA system indispensable to all scientists who need immediate access to fast and simple cell culture monitoring and screening assays.
Current cell monitoring and screening assays include the ViaCount assay for cell counting, apoptosis, and viability assessent, all in one test; the Express assay for a variety of applications, including protein expression, hybridoma screening, CD marker identification, bead based supernatant protein/antigen quantification, compound profiling, intracellular protein expression and GPCR expression, and three apoptosis assays for the detection of early, mid- and late apoptotic events.
From the quick installation and minimal training time required for operation, to the rapid assay results, the Guava PCA system is designed to save the operator time, every step of the way. Designed to accelerate cell-based discovery, the Guava PCA offers turnkey operation in an integrated system consisting of the compact PCA instrument, software to automatically analyse and archive data, and optimised reagents.
To accommodate evolving assay needs, the Guava PCA system is expandable.
